In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ChromaVision to raise up to $12mm in private placement

Executive Summary

ChromaVision Medical Systems (cellular imaging diagnostics) is raising a total of $12mm through the private placement of 561k common shares at $12.48 each--a (pr)14% premium to market price--and 56k purchase warrants to existing investors Safeguard Scientifics and IncuVest, both technology company incubators.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Cytology
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies